Suppr超能文献

新型双环唑胺类作为代谢型谷氨酸受体 5 的负变构调节剂的设计、合成及构效关系研究。

Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5.

机构信息

Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752, USA.

出版信息

J Med Chem. 2010 Oct 14;53(19):7107-18. doi: 10.1021/jm100736h.

Abstract

A novel series of diaryl bicyclic azole-amines that are potent selective negative modulators of metabotropic glutamate receptor 5 (mGluR5) were identified through rational design. An initial hit compound 5a of modest potency (IC(50) = 1.2 μM) was synthesized. Evaluation of structure-activity relationships (SAR) on the left-hand side of the molecule revealed a preference for a 2-substituted pyridine group linked directly to the central heterocycle. Variation of the central azolo-amine portion of the molecule revealed a preference for the [4,5-c]-oxazoloazepine scaffold, while right-hand side variants showed a preference for ortho- and meta-substituted benzene rings linked directly to the tertiary amine of the saturated heterocycle. These iterations led to the synthesis of 29b, a potent (IC(50) = 16 nM) and selective negative modulator that showed good brain penetrance, high receptor occupancy, and a duration of action greater than 1 h in rat when administered intraperitoneally. Formal PK studies in rat and Rhesus monkey revealed a short half-life that was attributable to high first-pass clearance.

摘要

通过合理设计,我们鉴定出了一系列新型二芳基双环唑烷胺类化合物,它们是代谢型谷氨酸受体 5(mGluR5)的有效、选择性负变构调节剂。我们合成了具有中等活性(IC50=1.2 μM)的初始命中化合物 5a。对分子左侧的构效关系(SAR)进行评估,发现人们更倾向于将直接连接到中环的 2-取代吡啶基团。对分子中环部分的进一步研究发现,[4,5-c]-噁唑并氮杂卓骨架更受青睐,而右侧的变体则更倾向于与饱和杂环的叔胺直接相连的邻位和间位取代苯环。经过这些迭代,我们合成了 29b,它是一种强效(IC50=16 nM)和选择性负变构调节剂,在大鼠中经腹腔给药时具有良好的脑穿透性、高受体占有率和超过 1 小时的作用持续时间。在大鼠和恒河猴中的正式 PK 研究表明,半衰期较短,这归因于高首过清除率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验